Last update 29 Nov 2024

MB-110

Overview

Basic Info

Drug Type
Gene therapy, Hematopoietic stem cell therapy
Synonyms
autologous CD34+ cells transduced with a lentiviral vector containing the human RAG1 gene, MB 110 - Mustang Bio, MB-110 - Mustang Bio
+ [7]
Target
RAG-1
Mechanism
RAG-1 stimulants(recombination activating 1 stimulants)
Therapeutic Areas
Immune System DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication
Severe Combined Immunodeficiency
Inactive Indication-
Originator Organization
Academisch Ziekenhuis LeidenAcademisch Ziekenhuis LeidenMustang Bio, Inc.Mustang Bio, Inc.
Active Organization
Academisch Ziekenhuis LeidenAcademisch Ziekenhuis LeidenMustang Bio, Inc.Mustang Bio, Inc.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

Related

1
Clinical Trials associated with MB-110
NCT04797260 / RecruitingNot ApplicableIIT
Phase I/II Clinical Trial of Autologous Hematopoietic Stem Cell Gene Therapy in RAG1-Deficient Severe Combined Immunodeficiency
100 Clinical Results associated with MB-110
Login to view more data
100 Translational Medicine associated with MB-110
Login to view more data
100 Patents (Medical) associated with MB-110
Login to view more data
100 Deals associated with MB-110
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Severe Combined ImmunodeficiencyPhase 2
NL
Mustang Bio, Inc.Mustang Bio, Inc.
22 Jul 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free